(Q44882510)

7 December 2017

Fexofenadine does not affect omeprazole pharmacokinetics: both are putative P-glycoprotein substrates (English)

1 reference

7 December 2017

1 reference

1 reference

2

Norio Yasui-Furukori

1 reference

7 December 2017

Takenori Takahata

1

1 reference

7 December 2017

Gen Yoshiya

3

1 reference

7 December 2017

Tsukasa Uno

4

1 reference

7 December 2017

Kazunobu Sugawara

5

1 reference

7 December 2017

Tomonori Tateishi

6

1 reference

7 December 2017

1 May 2004

1 reference

Basic and Clinical Pharmacology and Toxicology

7 December 2017

1 reference

7 December 2017

94

1 reference

7 December 2017

252-256

1 reference

7 December 2017

5

1 reference

Uptake and efflux of the peptidic delta-opioid receptor agonist

7 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2004.PTO940509.X

MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2004.PTO940509.X

The effect of rifampin administration on the disposition of fexofenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2004.PTO940509.X

A human lymphocyte based ex vivo assay to study the effect of drugs on P-glycoprotein (P-gp) function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2004.PTO940509.X

Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2004.PTO940509.X

Fexofenadine transport in Caco-2 cells: inhibition with verapamil and ritonavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2004.PTO940509.X

Verapamil competes with doxorubicin for binding to anionic phospholipids resulting in increased internal concentrations and rates of passive transport of doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2004.PTO940509.X

Effect of St John's wort on the pharmacokinetics of fexofenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2004.PTO940509.X

The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2004.PTO940509.X

Simultaneous determination of omeprazole and its metabolites in plasma and urine by reversed-phase high-performance liquid chromatography with an alkaline-resistant polymer-coated C18 column

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2004.PTO940509.X

10.1111/J.1742-7843.2004.PTO940509.X

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference